Biomarkers for detecting and improving AKI after liver transplantation: From diagnosis to treatment

Jing Liu,Yi Zhao,Zhen-Qiong Li,Qing Chen,Chang-Qing Luo,Jin-Xuan Su,Yu-Mei Wang

DOI: https://doi.org/10.1016/j.trre.2021.100612

IF: 3.066

2021-04-01

Transplantation Reviews

Abstract:<p>Orthotopic liver transplantation (OLT) is a well-established treatment for patients with liver failure. The shortage of donor organs and postoperative complications remain major obstacles for improving patient survival. Among these complications, acute kidney injury (AKI) is one of the most frequent types, contributing to graft loss. The timely detection and reversal of AKI can reduce its adverse influences on graft and patient outcomes. Traditional markers for detecting AKI are often limited with regard to their accuracy and specificity, and the discovery of better AKI markers and therapeutic targets assumes great importance. During past decades, studies directed toward early detection and treatment of AKI in OLT have been available. This review summarizes the evidence of these biomarkers for the prediction, diagnosis, treatment and prognosis stratification of AKI associated with OLT.</p>

immunology,transplantation

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to detect and improve acute kidney injury (AKI) earlier and more accurately after orthotopic liver transplantation (OLT). Specifically:

1. **High Incidence of AKI and Its Impact**: The incidence of AKI after OLT is as high as 64%, and it is closely related to graft loss and poor patient prognosis. Timely detection and reversal of AKI can reduce its adverse effects on grafts and patient outcomes.

2. **Limitations of Traditional Markers**: Traditional AKI detection markers (such as serum creatinine and urine output) have limitations in terms of sensitivity and specificity and cannot accurately diagnose AKI at an early stage. Therefore, the discovery of better AKI markers is crucial for early diagnosis, assessment of the duration of kidney injury, and prediction of patient prognosis.

3. **Search for New Biomarkers**: In order to overcome the shortcomings of traditional markers, researchers are committed to discovering and evaluating new biomarkers, which can detect AKI earlier and more accurately after OLT and help assess treatment effects and prognosis.

The paper summarizes the research progress on biomarkers for detecting and monitoring AKI after OLT in recent years, aiming to provide more effective tools for the clinic to manage this complication.